US Bancorp’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-850
Closed -$2K 4311
2022
Q3
$2K Sell
850
-793
-48% -$3.37K ﹤0.01% 3890
2022
Q2
$8K Buy
+1,643
New +$8.61K ﹤0.01% 3455

Other funds holding CELL

US Bancorp's CELL Position: Q4 2022 in Review

US Bancorp sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 850 shares — an estimated $2K sold.

US Bancorp first reported a position in CELL in Q2 2022 and held it in 2 quarters. The position peaked at $8K in Q2 2022. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

  • US Bancorp reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 850 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $2K.
  • US Bancorp first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • US Bancorp's PhenomeX Inc. Common Stock position peaked at $8K in Q2 2022.
  • 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.